Sawai To Double Plant's Production Capacity Under $53 Million Plan
This article was originally published in PharmAsia News
Executive Summary
Japan's Sawai Pharmaceutical said it plans to double the generics-making capacity of one of its local plants, enabling it to produce 4 billion tablets a year.